PMID: 9533756Apr 9, 1998Paper

An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women

International Journal of Cancer. Journal International Du Cancer
A HellandK S Rønningen

Abstract

Several recent studies have reported different associations between HLA specificities and human papillomavirus (HPV)-associated disease of the cervix. We report the distribution of DQA1 and DQB1 genes and HPV infection in a population-based case-control study including 92 patients with histologically verified cervical intraepithelial neoplasia grade II-III (CIN II-III) (thus including moderate and severe dysplasia and carcinoma in situ) and 225 control subjects. We found an overrepresentation of the DQA1*0102-DQB1*0602 haplotype among HPV-positive cases compared with controls. The association was even stronger when comparing HPV-16-positive cases with HPV-16-positive controls. In addition, among HPV-16-positive individuals, we observed a decreased frequency of DQA1*0102-DQB1*0604 in cases compared with controls. We were not able to detect any association between CIN II-III and DQB1*03. Compared with previous findings in cervical cancer, our data indicate that carrying the DQA1*0102-DQB1*0602 haplotype gives an increased risk of developing CIN when infected with HPV-16, without influencing progression to cancer.

References

Jul 4, 1992·Lancet·A L DavidV R Tindall
Mar 5, 1992·Nature·S S GlewP A Dyer
Mar 5, 1992·Nature·A HellandE Thorsby
Nov 22, 1991·Science·H zur Hausen
Sep 1, 1990·Gynecologic Oncology·M MaimanJ Boyce
Dec 1, 1990·Human Immunology·K S RønningenE Thorsby
Aug 1, 1982·Tissue Antigens·N PanzaS Zappacosta
May 4, 1995·International Journal of Cancer. Journal International Du Cancer·A O OlsenP Magnus
Dec 1, 1994·Journal of Clinical Pathology·W Z MehalK A Fleming
Jun 15, 1994·International Journal of Cancer. Journal International Du Cancer·K U PetryI Schedel
Feb 13, 1993·Lancet·C VandenveldeD van Beers
Feb 1, 1994·The Journal of Infectious Diseases·A HildesheimM E Sherman
May 15, 1994·International Journal of Cancer. Journal International Du Cancer·L GregoireW D Lancaster
Jun 16, 1993·Journal of the National Cancer Institute·M H SchiffmanS Wacholder
Dec 1, 1995·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·I KockumA Lernmark
Jan 1, 1996·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·K GjøoenI Orstavik
Jun 21, 1996·International Journal of Cancer. Journal International Du Cancer·X Sastre-GarauD Charron
Sep 4, 1996·International Journal of Cancer. Journal International Du Cancer·K OdunsiT S Ganesan
Nov 15, 1996·International Journal of Cancer. Journal International Du Cancer·A O OlsenP Magnus
Mar 1, 1997·Tissue Antigens·J G BodmerP I Terasaki

❮ Previous
Next ❯

Citations

Jan 21, 2006·International Journal of Cancer. Journal International Du Cancer·Yuping WuAnlong Xu
Aug 19, 2004·International Journal of Cancer. Journal International Du Cancer·Malin T EngelmarkUlf B Gyllensten
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Mehran GhaderiCarani B Sanjeevi
May 21, 2005·International Journal of Cancer. Journal International Du Cancer·Anna H BeskowUlf B Gyllensten
Aug 24, 2001·International Journal of Cancer. Journal International Du Cancer·A H BeskowU B Gyllensten
Mar 21, 2008·International Journal of Cancer. Journal International Du Cancer·Steven AdesUNKNOWN Biomarkers of Cervical Cancer Risk (BCCR) Study Team
Jun 25, 2020·International Journal of Cancer. Journal International Du Cancer·Dhanya RamachandranThilo Dörk
Aug 24, 1999·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·P C Maciag, L L Villa
Dec 24, 2003·The Cancer Journal·Eduardo L FrancoDebbie Saslow
Apr 17, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M SaitoH Maeda
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S. ChenS. M. Garland
Apr 1, 2006·Tissue Antigens·W J KoskinenL-M Aaltonen
Sep 2, 1999·British Journal of Cancer·P A Lazo
Jul 13, 2001·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M C AbbaC D Golijow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.